Intranasal Administration of Modified Vaccinia Virus
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization :
Other organizations : Medizinische Hochschule Hannover, University of Veterinary Medicine Hannover, Foundation, Center for Experimental and Clinical Infection Research, Helmholtz Centre for Infection Research, Ludwig-Maximilians-Universität München
Variable analysis
- Recombinant modified vaccinia virus Ankara (MVA) viruses
- Infectious units (IU)
- Mice were deeply anesthetized with a mixture of Ketamine and Xylazine
- MVA was diluted to a final concentration of 3.3 × 10^8 IU/ml in PBS
- 30 μl (10^7 IU) of MVA was administered intranasally
- No positive or negative controls were explicitly mentioned in the provided information.
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!